Sorrento Therapeutics, Inc.
SRNE
SRNE was delisted on the 22nd of February, 2023.
88 hedge funds and large institutions have $124M invested in Sorrento Therapeutics, Inc. in 2015 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 27 increasing their positions, 23 reducing their positions, and 14 closing their positions.
121% more call options, than puts
Call options by funds: $6.2M | Put options by funds: $2.81M
93% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 14
17% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 23
17% more funds holding
Funds holding: 75 → 88 (+13)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
47% less capital invested
Capital invested by funds: $235M → $124M (-$111M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WCM
Wildcat Capital Management
New York
|
+$15.5M |
| 2 |
NI
Numeric Investors
Boston,
Massachusetts
|
+$8.32M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$5.89M |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$3.64M |
| 5 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$3.36M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Aisling Capital
New York
|
-$21.5M |
| 2 |
EI
EAM Investors
Solana Beach,
California
|
-$4.39M |
| 3 |
Morgan Stanley
New York
|
-$2.13M |
| 4 |
HCMT
Highland Capital Management (Texas)
Dallas,
Texas
|
-$2.03M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$1.8M |
SRNE Hedge Fund Activity: Q3 2015 in Review
88 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in Sorrento Therapeutics, Inc. (SRNE) for Q3 2015, worth a combined $124M — down 47% from $235M a quarter earlier.
Buyers outnumbered sellers: 27 funds opened new SRNE positions and 14 closed out — a net gain of 13 holders — while 27 added to existing stakes and 23 trimmed.
The largest buyer was Wildcat Capital Management, adding an estimated $15.5M. The largest seller was Aisling Capital, cutting an estimated $21.5M.
- 88 institutional investors held Sorrento Therapeutics, Inc. (SRNE) as of Q3 2015, up from 75 in Q2 2015.
- Funds reported $124M of Sorrento Therapeutics, Inc. stock for Q3 2015, down 47% quarter-over-quarter.
- 27 funds opened new Sorrento Therapeutics, Inc. positions in Q3 2015 and 14 closed out, a net change of +13 holders.
- The largest Sorrento Therapeutics, Inc. buyer in Q3 2015 was Wildcat Capital Management, an estimated $15.5M added.
- The largest Sorrento Therapeutics, Inc. seller in Q3 2015 was Aisling Capital, an estimated $21.5M sold.
Based on aggregated 13F filings for Q3 2015.